Clinicopathological features and prognostic factors of patients with lung metastasis of stage Ⅰa~Ⅲb cervical cancer.
10.3760/cma.j.cn112152-20211230-00984
- VernacularTitle:Ⅰa~Ⅲb期宫颈癌肺转移患者的临床病理特征和预后影响因素
- Author:
Hong LIU
1
;
Guo Nan ZHANG
1
;
Min LUO
2
;
Xu Dong ZHANG
3
;
Ying FAN
1
;
Chun Rong PENG
1
Author Information
1. Departments of Gynecological Oncology, Sichuan Cancer Hospital & Institute, Cancer Hospital Affiliated to University of Electronic Science and Technology of China, Chengdu 610041, China.
2. School of Medicine, University of Electronic Science and Technology of China, Chengdu 610054, China.
3. GCP office, Sichuan Cancer Hospital & Institute, Cancer Hospital Affiliated to University of Electronic Science and Technology of China, Chengdu 610041, China.
- Publication Type:Journal Article
- Keywords:
Prognosis;
Pulmonary metastasis;
Therapy;
Uterine cervical neoplasms
- MeSH:
Female;
Humans;
Prognosis;
Uterine Cervical Neoplasms/pathology*;
Neoplasm Staging;
Retrospective Studies;
Lung Neoplasms/pathology*;
Survival Rate
- From:
Chinese Journal of Oncology
2023;45(4):340-347
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To investigate the clinicopathological features and prognostic factors of lung metastasis in patients with cervical cancer after treatment. Methods: The clinicopathological data of 191 patients with lung metastasis of stage Ⅰa-Ⅲb cervical cancer (FIGO 2009 stage) treated in Sichuan Cancer Hospital from January 2007 to December 2020 were analyzed retrospectively. Kaplan Meier method and Log rank test were used for survival analysis, and Cox regression model was used for prognostic factors analysis. Results: Among 191 patients with lung metastasis of cervical cancer, pulmonary metastasis was found in 134 patients (70.2%) during follow-up examination, and 57 patients (29.8%) had clinical symptoms (cough, chest pain, shortness of breath, hemoptysis, and fever). The time from the initial treatment of cervical cancer to the discovery of lung metastasis was 1-144 months in the whole group, with a median time of 19 months. Univariate analysis of the prognosis of lung metastasis after treatment of cervical cancer showed that the diameter of cervical tumor, lymph node metastasis, positive surgical margin, disease-free interval after treatment of cervical cancer, whether it is accompanied by other metastasis, the number, location and maximum diameter of lung metastasis, and the treatment method after lung metastasis are related to the prognosis of patients with lung metastasis of cervical cancer. Multivariate analysis showed that the number of lung metastases and other site metastases in addition to lung metastases were independent factors affecting the prognosis of patients with lung metastases of cervical cancer (P<0.05). Conclusions: For patients with cervical cancer, attention should be paid to chest CT examination during follow-up to guard against the possibility of lung metastasis after treatment. Besides lung metastasis, other site metastasis and the number of lung metastasis are independent factors affecting the prognosis of patients with lung metastasis of cervical cancer. For patients with lung metastasis after treatment of cervical cancer, surgical treatment is an effective treatment. It is necessary to strictly grasp the surgical indications, and some patients can achieve long-term survival. For patients with lung metastasis of cervical cancer who are not suitable for resection of lung metastasis, the remedial treatment of chemotherapy with or without radiotherapy is still a recommended choice.
